1-5 of 5
John F Seymour, MD, FRACP
Close
Save search
Sort by
Journal Articles

Plerixafor Plus Single-Dose Pegfilgrastim for Hematopoietic Stem and Progenitor Cell Mobilization: An Efficient and Safe Regimen In Good and Poor Mobilizer Patients

Free
Kirsten Herbert, MD, BSci(Med), FRACP, PhD, Lisa Demosthenous, Glen Wiesner, PhD, Emma Link, PhD, David Alan Westerman, MBBS, FRACP, FRCPA, Neil Came, MBBS, FRACP, FRCPA, John F Seymour, MD, FRACP, PhD, Miles Prince, MD, FRACP, FRCPA
Journal: Blood
Blood (2010) 116 (21): 2256.
https://doi.org/10.1182/blood.V116.21.2256.2256
Published: 2010
Journal Articles

Achievement of Red Blood Cell (RBC) Transfusion Independence with Azacitidine (AZA) Leads to Improved Survival In Patients with Higher-Risk Myelodysplasias Regardless of Baseline Transfusion Needs

Free
John F Seymour, MD, FRACP, Valeria Santini, MD, Pierre Fenaux, MD, Aristoteles A.N. Giagounidis, MD, Guillermo F. Sanz, MD, PhD, Carlo Finelli, MD, Lela M. Lucy, MS, Jay Backstrom, MD, MPH, CL Beach, PharmD
Journal: Blood
Blood (2010) 116 (21): 1856.
https://doi.org/10.1182/blood.V116.21.1856.1856
Published: 2010
Journal Articles

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Free
Judith Trotman, MBChB, FRACP, FRCPA, Marion Fournier, Thierry Lamy, MD, PhD, Jane A Estell, MBBS, FRCPA, FRACP, Anne Sonet, MD, Andrea Janikova, MD, PhD, Herve Tilly, Didier Decaudin, Jean Gabarre, MD, John F Seymour, MD, FRACP, Etienne Garin, Cecily Forsyth, Michael Fulham, MBBS, FRACP, Thierry Vander Borght, MD, PhD, Ofer Shpilberg, MD, MPH, Gilles Salles
Journal: Blood
Blood (2010) 116 (21): 855.
https://doi.org/10.1182/blood.V116.21.855.855
Published: 2010
Journal Articles

The Safety and Tolerability of Oral Fludarabine, ±oral Cyclophosphamide and Iv Rituximab Therapy In Previously Untreated Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – Interim Analysis From the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study.

Free
Stephen P Mulligan, MBBS, PhD, FRACP, FRCPA, Devinder S Gill, MD, William E. P. Renwick, MBBS, FRACP, Melanie L Sulda, BSc, Ph.D, O. Giles Best, BSc, PhD, Bryone J Kuss, PhD, FRCPA, FRACP, MBBS, John F Seymour, MD, FRACP
Journal: Blood
Blood (2010) 116 (21): 699.
https://doi.org/10.1182/blood.V116.21.699.699
Published: 2010
Journal Articles

Re-Evaluation of the Efficacy of Azacitidine (AZA) In Patients From the AZA-001 Study with Higher-Risk Myelodysplastic Syndromes (MDS) Classified by WHO Criteria and WPSS Risk

Free
Norbert Gattermann, MD, Guillermo F. Sanz, MD, PhD, Aristoteles Giagounidis, John F Seymour, MD, FRACP, Pierre Fenaux, MD, PhD, Valeria Santini, MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Petra Muus, MD, PhD, Fernando Ramos, MD, Lela M. Lucy, MS, CL Beach, PharmD, Lewis R. Silverman, MD
Journal: Blood
Blood (2010) 116 (21): 4031.
https://doi.org/10.1182/blood.V116.21.4031.4031
Published: 2010